When will Wegovy be available in the UK?

The combination of nutrition, regular exercise and a healthy lifestyle is important when on a weight loss journey — but, it's not always enough to move the needle. And, this may have you considering weight loss medication as a way to help kickstart weight loss.

One medication that is top of mind at the moment is Wegovy — this weight-loss injection has been shown to deliver positive results when it comes to helping patients lose weight and reach their ideal body weight. Some high street pharmacies have promised they will be prescribing the drug when it's in market.

With this in mind, let's look at how this weight loss drug works, how to access it and when to expect its release in the UK.

When will Wegovy be available in the UK?

As of September 4, 2023, Wegovy has been available in the UK.

While other weight loss medicines containing semaglutide, like Ozempic, have been available since January 2019, Wegovy was not available in the UK until September 2023. It was approved by the UK Medicines and Health products Regulations Agency (MHRA) in September 2021.

Wegovy is recommended for weight management in people with or without type 2 diabetes and is considered safe with only mild to moderate side effects, such as a sore stomach and nausea [5][6].

Wegovy, like any prescription medication, may not work for everyone, and like with any medication, side effects are possible. That means it's important to make sure that you see a trusted healthcare professional before starting your medicated weight loss journey.

Our clinical team can assess your eligibility for the Juniper Programme which combines weight loss medication including Wegovy with clinical care and lifestyle changes to achieve long-term sustainable weight loss.

What is Wegovy?

Wegovy is a weight loss medication that uses the active ingredient, semaglutide. Injected once a week into the stomach, thigh or upper arm, Wegovy helps to manage appetite, reducing food intake and helping you to feel fuller for longer.

And, the weight loss results are particularly promising, with clinical trials showing that at 68 weeks of consistent semaglutide use, the average total body weight loss was 14.9% [1].

Although more recent data on Wegovy’s 7.2mg dose show average weight loss of 20.7% after 72 weeks [9], demonstrating how effective it is when used consistently and with the right support.

With Juniper, Wegovy is delivered as part of a complete programme that includes expert care, coaching, and tracking tools — to help you get the most from your treatment.

Wegovy injections come in a variety of doses. The dosage will typically start quite low for weeks 1-4. After this, the dose will gradually be increased until you reach the maintenance dose at around week 17, and it will stay the same for the rest of your time using Wegovy.

How does Wegovy work?

With results widely documenting it as a highly efficient weight loss medication and added benefits like reducing the risk of heart disease and cardiovascular events [2], you may be wondering how does Wegovy help you lose weight?

Wegovy uses the active ingredient semaglutide (a glucagon-like peptide-1, or GLP-1 for short) which is a hormone that is naturally present in your body that helps to regulate appetite [2].

GLP-1 helps to reduce the amount of sugar produced in the liver, boost basal insulin, as well as decreasing appetite. By mimicking this naturally occurring hormone, Wegovy helps you manage your calorie intake.

Wegovy helps to lower your appetite and makes it easier to maintain a reduced-calorie diet, too. But it's important to remember that while Wegovy does help you reduce overall calorie intake, it's best to maintain a healthy diet, with a wide range of fresh ingredients and nutrients, for optimal health benefits.

Who can use Wegovy?

To get a private prescription for Wegovy, you will need to have a body mass index (BMI) of 30 or over, or have a BMI of 27 and over, with additional health conditions related to body weight, such as high blood pressure [4]. Different criteria apply for NHS treatment in England.

It's typically not advised you take Wegovy if you meet one of the following:

• You're pregnant or breastfeeding 
• You have liver, kidney or heart failure, an eating disorder or pancreatitis 
• You're taking insulin, sulphonylureas; or
• If you're already taking other weight loss drugs that work in a similar way

If you're curious about the weight loss injection Wegovy but aren't sure if you qualify for a prescription, speaking to a trusted healthcare professional will help determine if you're eligible for Wegovy or any other weight loss treatment.

Is Wegovy available in the UK NHS?

The National Institute for Health and Care Excellence (NICE) has recommended weight loss medications for use within the NHS in England for weight management in adults, alongside a reduced-calorie diet and increased physical activity. To be eligible, you must have at least one weight-related comorbidity and a body mass index (BMI) of at least 35. However, due to cost restrictions, Wegovy is not available to all eligible patients. Access requires a referral to an NHS specialist weight management service and waiting for eligibility assessment.


However, if you are not eligible to claim Wegovy on the NHS, it will still be available, at cost, from pharmacies. Either way, you will need a prescription. But this means that chemists won't be able to provide the drug as a part of a programme of wider support.


If you find that you're not eligible for Wegovy on the NHS, it's important to seek out a community of like-minded people and maintain access to healthcare professionals so that you can ensure your weight loss journey is successful and sustainable.

Can you switch from another weight loss medication to Wegovy?

Yes! If you're thinking about switching medications, the good news is that it's both safe and straightforward.

From 1 September 2025, Eli Lilly, the manufacturer of Mounjaro (tirzepatide), will increase its UK list price to align with other developed countries. This nationwide change applies to providers including pharmacies, private clinics, and digital platforms.

In response, we’ve lowered the price of our Wegovy programme by 25%, and we’re making it easier for patients to switch without starting over, so that effective treatment remains within reach for as many people as possible.

So, if you've been wondering if you can switch from Mounjaro to Wegovy, the good news is that it's both safe and straightforward.

When making the switch, Juniper patients don’t need to restart at the lowest dose. If clinically appropriate, they can continue at a higher dose aligned with recent treatment history. We also only require a 7-day gap between your last Mounjaro dose and your first Wegovy dose — unlike most providers, who require 28 days.

At Juniper, we make that switch seamless and fully supported — so you can protect your progress without paying more than you need to. Our clinical switching protocol is is simple and safe:

• ‍Review — Your clinician assesses your treatment history and dose tolerance.‍
• Match — If eligible, you start on an equivalent high dose to avoid losing progress.‍
• Transition — Only a 7-day window is required between your last Mounjaro dose and your first Wegovy dose (most providers require 28 days).‍
• Support — Pharmacist check-ins, dose adjustments, and lifestyle guidance keep you on track.

Start your Wegovy switch today →